BOSSI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 3.223
EU - Europa 2.447
AS - Asia 1.965
SA - Sud America 293
OC - Oceania 241
AF - Africa 139
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.310
Nazione #
US - Stati Uniti d'America 3.062
IT - Italia 766
CN - Cina 528
IN - India 409
SE - Svezia 288
DE - Germania 257
FR - Francia 236
AU - Australia 228
GB - Regno Unito 206
JP - Giappone 204
BR - Brasile 192
IL - Israele 122
CA - Canada 117
TR - Turchia 111
ES - Italia 109
TW - Taiwan 95
HK - Hong Kong 80
IE - Irlanda 78
NL - Olanda 60
PL - Polonia 57
KR - Corea 55
IR - Iran 51
VN - Vietnam 46
CH - Svizzera 45
ZA - Sudafrica 45
CL - Cile 41
MY - Malesia 41
TH - Thailandia 39
RU - Federazione Russa 38
PK - Pakistan 36
EG - Egitto 35
MX - Messico 34
CZ - Repubblica Ceca 33
RO - Romania 33
FI - Finlandia 32
ID - Indonesia 32
GR - Grecia 31
BE - Belgio 28
SG - Singapore 27
CO - Colombia 22
PT - Portogallo 22
SA - Arabia Saudita 20
NO - Norvegia 18
AT - Austria 17
DK - Danimarca 15
PE - Perù 13
PH - Filippine 13
BD - Bangladesh 12
HR - Croazia 11
NZ - Nuova Zelanda 11
IQ - Iraq 9
UA - Ucraina 9
BG - Bulgaria 8
HU - Ungheria 8
AR - Argentina 7
GH - Ghana 7
LT - Lituania 7
RS - Serbia 7
TZ - Tanzania 7
UY - Uruguay 7
KE - Kenya 6
MA - Marocco 6
MK - Macedonia 6
SI - Slovenia 6
TN - Tunisia 6
BY - Bielorussia 5
DZ - Algeria 5
VE - Venezuela 5
EC - Ecuador 4
IS - Islanda 4
JO - Giordania 4
LY - Libia 4
NP - Nepal 4
SY - Repubblica araba siriana 4
AE - Emirati Arabi Uniti 3
BT - Bhutan 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
MW - Malawi 3
SD - Sudan 3
SN - Senegal 3
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
PG - Papua Nuova Guinea 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
AN - Antille olandesi 1
ER - Eritrea 1
KW - Kuwait 1
LU - Lussemburgo 1
MT - Malta 1
Totale 8.299
Città #
Stockholm 266
Ashburn 204
Houston 196
Fairfield 170
Seattle 97
Woodbridge 87
Chicago 82
Shanghai 77
Ann Arbor 73
Brescia 69
Dublin 68
Milan 61
Buffalo 57
Palaiseau 57
Taipei 57
Melbourne 56
Rome 55
Beijing 54
Bengaluru 52
Cambridge 50
Mumbai 49
Wilmington 47
Delhi 40
Los Angeles 39
New York 38
Guangzhou 37
Paris 36
Chengdu 33
Fleming Island 33
Hyderabad 32
San Diego 31
Dong Ket 30
Tokyo 30
Warsaw 30
Central District 29
Nuremberg 28
Sydney 27
Helsinki 26
Ottawa 26
Boardman 23
Hefei 23
Istanbul 23
Jerusalem 23
Nanjing 22
São Paulo 22
Hangzhou 21
Bangkok 20
Central 20
London 20
Portland 20
San Francisco 20
Turin 19
Athens 18
Berlin 18
Brisbane 18
Dallas 18
Santiago 18
Tel Aviv 18
Toronto 18
Adelaide 17
Chennai 17
Des Moines 17
Las Vegas 17
Mexico City 17
Cape Town 16
Changsha 16
Frankfurt am Main 16
Hamburg 16
Ankara 15
Brooklyn 15
Kumar 15
Manchester 15
Pune 15
Atlanta 14
Chiba 14
Gurgaon 14
San Antonio 14
Wuhan 14
Henderson 13
Madrid 13
Padova 13
Bologna 12
Cairo 12
Fortaleza 12
Izmir 12
Muizenberg 12
Seoul 12
Tappahannock 12
Verona 12
Jakarta 11
Karachi 11
Lima 11
Philadelphia 11
Redmond 11
Singapore 11
Azzano San Paolo 10
Boydton 10
Campinas 10
Cedar Knolls 10
Chongqing 10
Totale 3.476
Nome #
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines, file ddc633e3-cc0b-4e2e-e053-3705fe0a4c80 2.068
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents, file ddc633e3-fd32-4e2e-e053-3705fe0a4c80 1.011
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing, file ddc633e4-1344-4e2e-e053-3705fe0a4c80 986
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients, file ddc633e4-04ea-4e2e-e053-3705fe0a4c80 517
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study, file ddc633e4-1e66-4e2e-e053-3705fe0a4c80 462
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma, file ddc633e4-30fb-4e2e-e053-3705fe0a4c80 440
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma, file ddc633e4-1d97-4e2e-e053-3705fe0a4c80 121
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio, file ddc633e3-c6a4-4e2e-e053-3705fe0a4c80 119
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions, file ddc633e4-1342-4e2e-e053-3705fe0a4c80 105
Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients: *MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers, file acdf5aa5-000b-4078-a1df-0fbbc527132d 101
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways, file ddc633e4-24c2-4e2e-e053-3705fe0a4c80 101
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets, file ddc633e4-4fbd-4e2e-e053-3705fe0a4c80 99
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma, file ddc633e4-25a9-4e2e-e053-3705fe0a4c80 98
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma, file ddc633e4-3436-4e2e-e053-3705fe0a4c80 90
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives, file ddc633e4-5bdc-4e2e-e053-3705fe0a4c80 90
Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines, file ddc633e4-6393-4e2e-e053-3705fe0a4c80 90
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements., file ddc633e3-ed12-4e2e-e053-3705fe0a4c80 87
Addressing the quality of life needs of older patients with cancer: A SIOG consensus paper and practical guide, file ddc633e4-6673-4e2e-e053-3705fe0a4c80 81
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients, file ddc633e4-2648-4e2e-e053-3705fe0a4c80 77
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development, file ddc633e4-20b4-4e2e-e053-3705fe0a4c80 70
The association between Vitamin D and gut microbiota: A systematic review of human studies, file ddc633e4-5a6c-4e2e-e053-3705fe0a4c80 69
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study, file ddc633e4-671b-4e2e-e053-3705fe0a4c80 69
The use of fentanyl in pain management in head and neck cancer patients: a narrative review, file ddc633e4-631c-4e2e-e053-3705fe0a4c80 62
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study, file ddc633e4-6279-4e2e-e053-3705fe0a4c80 61
Prognostic significance of cd4+ and cd8+ tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: A meta-analysis, file ddc633e4-3e08-4e2e-e053-3705fe0a4c80 57
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases, file ddc633e4-5670-4e2e-e053-3705fe0a4c80 57
The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?, file ddc633e4-6f59-4e2e-e053-3705fe0a4c80 55
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic, file ddc633e4-6246-4e2e-e053-3705fe0a4c80 54
Malnutrition management in oncology: An expert view on controversial issues and future perspectives, file 850747bb-c850-48b6-95f1-ab45d705fc9d 50
Prognostic value of H-index in patients surgically treated for squamous cell carcinoma of the larynx, file ddc633e4-5de6-4e2e-e053-3705fe0a4c80 50
Sinonasal squamous cell carcinoma, a narrative reappraisal of the current evidence, file ddc633e4-5abb-4e2e-e053-3705fe0a4c80 48
Nutrition in patients with cancer: A new area for medical oncologists? A practising oncologist's interdisciplinary position paper, file ddc633e4-608b-4e2e-e053-3705fe0a4c80 47
What to do and what not to do in the management of cancer pain: A physician survey and expert recommendations, file ddc633e4-65b8-4e2e-e053-3705fe0a4c80 45
Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer, file ddc633e4-5cc4-4e2e-e053-3705fe0a4c80 44
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial, file ddc633e4-5c1f-4e2e-e053-3705fe0a4c80 43
The role of benzydamine in prevention and treatment of chemoradiotherapy-induced mucositis, file ddc633e4-5e17-4e2e-e053-3705fe0a4c80 43
Overview of oral potentially malignant disorders: From risk factors to specific therapies, file ddc633e4-5cbe-4e2e-e053-3705fe0a4c80 41
Prognostic Nutritional Index: An easy nutritional screening for patients with head and neck cancer?, file ddc633e4-5cc8-4e2e-e053-3705fe0a4c80 41
The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: A narrative review, file ddc633e4-5de8-4e2e-e053-3705fe0a4c80 41
Editorial: Advances in the Multidisciplinary Management of Oral Cancer, file ddc633e4-5f85-4e2e-e053-3705fe0a4c80 40
Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy, file ddc633e4-5fa4-4e2e-e053-3705fe0a4c80 40
Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters, file 2e2e90d3-50dc-42fa-91db-a3a833ae18f1 39
Recurrent/metastatic squamous cell carcinoma of the head and neck: A big and intriguing challenge which may be resolved by integrated treatments combining locoregional and systemic therapies, file ddc633e4-6120-4e2e-e053-3705fe0a4c80 37
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials, file ddc633e4-62b5-4e2e-e053-3705fe0a4c80 37
Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study, file ddc633e4-5962-4e2e-e053-3705fe0a4c80 33
Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives, file ddc633e4-6fea-4e2e-e053-3705fe0a4c80 33
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial, file ddc633e4-4d0f-4e2e-e053-3705fe0a4c80 31
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions, file ddc633e4-6f57-4e2e-e053-3705fe0a4c80 31
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial, file 7d17a536-56c5-466f-8e35-218df8b0aa67 29
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders, file ddc633e4-65f0-4e2e-e053-3705fe0a4c80 29
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy?, file ddc633e4-671d-4e2e-e053-3705fe0a4c80 27
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia, file ddc633e4-5afd-4e2e-e053-3705fe0a4c80 25
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy, file ddc633e4-671e-4e2e-e053-3705fe0a4c80 23
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, file e3da00a3-4db0-4bb7-8f34-7efaf13d2c43 22
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022, file 5323863e-3f58-415d-9746-557624e118e0 18
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy, file ddc633e4-6f5a-4e2e-e053-3705fe0a4c80 18
The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts, file ddc633e4-686f-4e2e-e053-3705fe0a4c80 16
Clinical use of photobiomodulation for the prevention and treatment of oral mucositis: the real-life experience of MASCC/ISOO members, file ce80715c-0195-46d5-a401-c5a7162d4e97 15
Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study, file ddc633e4-6899-4e2e-e053-3705fe0a4c80 15
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group, file ddc633e4-6871-4e2e-e053-3705fe0a4c80 13
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study, file eeac2dd5-94fb-4be9-965d-fbc3a99c1c85 13
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer, file 201a3d6b-e386-4233-b50a-988884fe08b7 12
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review, file a3dc087a-4417-4f8f-b8c1-37f0f387d243 12
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice, file f44bc3e5-2328-484c-a51c-6557effdc03c 12
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio, file ddc633e3-c6a5-4e2e-e053-3705fe0a4c80 11
Treatment of cutaneous squamous cell carcinoma with immune checkpoint inhibitors in special populations, file ddc633e4-683c-4e2e-e053-3705fe0a4c80 11
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel, file 995ba39f-2e7d-4e90-8563-8e83b79b019e 10
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations, file f09e45f2-e6ff-4777-9a65-004230649b7a 10
Confounding factors in the assessment of oral mucositis in head and neck cancer, file 011b68ab-350d-4b7a-8638-2793f828864f 9
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258], file 1f5ecf27-f99b-4ebf-8e0b-b012514f9a18 9
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders, file 29427f2e-7f57-400f-b580-eb270926bb0e 8
Unmet Needs and Perspectives in Oral Cancer Prevention, file 93d19bdf-cd91-4e82-81c4-ca48d8b2cd93 8
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases, file 95f34938-1541-4885-94b0-17738ca8073c 7
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis, file d1ec1fcb-8f36-4812-8c2e-c467a33cc70e 7
Personalized Medicine in Skull Base and Sinonasal Tumors, file 0854f2da-2613-414d-8a1c-7bf7e3920a2c 6
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement, file ddc633e3-25d0-4e2e-e053-3705fe0a4c80 4
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways, file b4e7aafa-3eb1-4246-aa8c-838f56f663d1 3
Cetuximab in the management of nasopharyngeal carcinoma - A narrative review, file ddc633e4-6514-4e2e-e053-3705fe0a4c80 2
Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis, file 94f0d825-06ce-4a6c-980b-72ec9fb89f63 1
Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis, file 99b221ec-dd08-4a52-8de7-935fe59bf332 1
Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer, file ddc633e3-c0b3-4e2e-e053-3705fe0a4c80 1
Management of sinonasal adenocarcinomas with anterior skull base extension, file ddc633e4-59ba-4e2e-e053-3705fe0a4c80 1
Sinonasal cancers treatments: state of the art, file ddc633e4-59d8-4e2e-e053-3705fe0a4c80 1
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort, file ddc633e4-5aa5-4e2e-e053-3705fe0a4c80 1
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials, file ddc633e4-5cc6-4e2e-e053-3705fe0a4c80 1
In Reply to Fakhry et al, file ddc633e4-5cca-4e2e-e053-3705fe0a4c80 1
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias, file ddc633e4-5d3e-4e2e-e053-3705fe0a4c80 1
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients, file ddc633e4-5d40-4e2e-e053-3705fe0a4c80 1
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation, file ddc633e4-5d67-4e2e-e053-3705fe0a4c80 1
The pathogenesis of mucositis: updated perspectives and emerging targets, file ddc633e4-5d6c-4e2e-e053-3705fe0a4c80 1
Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial, file ddc633e4-5e22-4e2e-e053-3705fe0a4c80 1
Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients, file ddc633e4-5f37-4e2e-e053-3705fe0a4c80 1
Malignant salivary gland tumours in families with breast cancer susceptibility, file ddc633e4-6075-4e2e-e053-3705fe0a4c80 1
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO), file ddc633e4-615b-4e2e-e053-3705fe0a4c80 1
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO), file ddc633e4-615d-4e2e-e053-3705fe0a4c80 1
Fatigue, a major still underestimated issue, file ddc633e4-6192-4e2e-e053-3705fe0a4c80 1
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer, file ddc633e4-6242-4e2e-e053-3705fe0a4c80 1
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma, file ddc633e4-62b7-4e2e-e053-3705fe0a4c80 1
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm, file ddc633e4-64a4-4e2e-e053-3705fe0a4c80 1
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines, file ddc633e4-6512-4e2e-e053-3705fe0a4c80 1
Totale 8.537
Categoria #
all - tutte 20.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.037

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020302 5 24 34 31 15 11 25 17 23 44 26 47
2020/20211.645 96 176 148 114 117 148 119 133 165 120 136 173
2021/20222.777 104 120 112 332 279 176 184 154 247 171 519 379
2022/20232.605 233 159 452 229 147 224 174 172 193 248 206 168
2023/20241.208 227 232 209 144 314 82 0 0 0 0 0 0
Totale 8.539